Marilena V. Iorio

25.1k total citations · 6 hit papers
59 papers, 17.6k citations indexed

About

Marilena V. Iorio is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Marilena V. Iorio has authored 59 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 40 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Marilena V. Iorio's work include MicroRNA in disease regulation (38 papers), Circular RNAs in diseases (26 papers) and Cancer-related molecular mechanisms research (26 papers). Marilena V. Iorio is often cited by papers focused on MicroRNA in disease regulation (38 papers), Circular RNAs in diseases (26 papers) and Cancer-related molecular mechanisms research (26 papers). Marilena V. Iorio collaborates with scholars based in Italy, United States and Mexico. Marilena V. Iorio's co-authors include Carlo M. Croce, Stefano Volinia, George A. Calin, Manuela Ferracin, Chang‐Gong Liu, Massimo Negrini, Amelia Cimmino, Sylvie Ménard, Rosa Visone and Fabio Petrocca and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Marilena V. Iorio

56 papers receiving 17.3k citations

Hit Papers

A microRNA expression sig... 2005 2026 2012 2019 2006 2005 2005 2012 2007 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilena V. Iorio Italy 30 14.8k 13.9k 1.6k 1.1k 638 59 17.6k
Amelia Cimmino Italy 28 11.5k 0.8× 10.3k 0.7× 877 0.5× 1.1k 1.0× 573 0.9× 50 14.2k
Ramiro Garzon United States 42 10.9k 0.7× 8.9k 0.6× 1.1k 0.7× 1.0k 1.0× 543 0.9× 142 13.5k
Leonardo Salmena Canada 31 13.9k 0.9× 9.0k 0.6× 1.9k 1.2× 1.5k 1.4× 721 1.1× 66 16.6k
Gregory J. Goodall Australia 61 13.3k 0.9× 9.5k 0.7× 2.8k 1.7× 1.6k 1.5× 443 0.7× 149 17.2k
Sven Diederichs Germany 47 12.4k 0.8× 11.1k 0.8× 1.9k 1.2× 784 0.7× 321 0.5× 112 15.6k
E. Alejandro Sweet‐Cordero United States 29 9.2k 0.6× 7.2k 0.5× 1.6k 1.0× 547 0.5× 446 0.7× 82 11.6k
Michael T. Hemann United States 49 9.2k 0.6× 4.5k 0.3× 3.3k 2.0× 1.1k 1.0× 616 1.0× 120 12.9k
Naohiko Seki Japan 70 12.1k 0.8× 8.2k 0.6× 2.1k 1.3× 1.1k 1.0× 811 1.3× 357 16.4k
Eva Hernando United States 52 10.6k 0.7× 5.6k 0.4× 3.3k 2.0× 2.0k 1.9× 613 1.0× 115 14.5k
Fabio Petrocca United States 29 9.2k 0.6× 8.3k 0.6× 1.7k 1.0× 620 0.6× 334 0.5× 39 11.0k

Countries citing papers authored by Marilena V. Iorio

Since Specialization
Citations

This map shows the geographic impact of Marilena V. Iorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilena V. Iorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilena V. Iorio more than expected).

Fields of papers citing papers by Marilena V. Iorio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilena V. Iorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilena V. Iorio. The network helps show where Marilena V. Iorio may publish in the future.

Co-authorship network of co-authors of Marilena V. Iorio

This figure shows the co-authorship network connecting the top 25 collaborators of Marilena V. Iorio. A scholar is included among the top collaborators of Marilena V. Iorio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilena V. Iorio. Marilena V. Iorio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cosimo, Serena Di, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.. (2024). A gene expression-based classifier for HER2-low breast cancer. Scientific Reports. 14(1). 2628–2628.
2.
Pizzamiglio, Sara, Chiara Maura Ciniselli, Evandro de Azambuja, et al.. (2024). Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO. Breast Cancer Research and Treatment. 206(2). 285–294. 4 indexed citations
3.
Cataldo, Alessandra, Ilaria Plantamura, Elda Tagliabue, et al.. (2022). The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective. Cancers. 14(21). 5326–5326. 18 indexed citations
4.
Pizzamiglio, Sara, Giulia Cosentino, Chiara Maura Ciniselli, et al.. (2021). What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study. Cancer Medicine. 11(2). 332–339. 8 indexed citations
5.
Romero‐Córdoba, Sandra, Iván Salido-Guadarrama, María E. Meneses, et al.. (2020). Mexican Ganoderma Lucidum Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet. Nutrients. 13(1). 38–38. 18 indexed citations
6.
Cataldo, Alessandra, Sandra Romero‐Córdoba, Ilaria Plantamura, et al.. (2020). MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer. Cancers. 12(8). 2261–2261. 18 indexed citations
7.
Cosimo, Serena Di, Valentina Appierto, Sara Pizzamiglio, et al.. (2019). Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial. Clinical Cancer Research. 25(13). 3887–3895. 46 indexed citations
8.
Romero‐Córdoba, Sandra, E. Meneghini, Milena Sant, et al.. (2019). Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation. Cancers. 11(7). 911–911. 34 indexed citations
9.
Romero‐Córdoba, Sandra, Sergio Rodrı́guez-Cuevas, Verónica Bautista‐Piña, et al.. (2018). Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer. Scientific Reports. 8(1). 12252–12252. 86 indexed citations
10.
D’Ippolito, Elvira, Ilaria Plantamura, Lucia Bongiovanni, et al.. (2016). miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. Cancer Research. 76(18). 5562–5572. 72 indexed citations
11.
Baroni, Sara, Sandra Romero‐Córdoba, Ilaria Plantamura, et al.. (2016). Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell Death and Disease. 7(7). e2312–e2312. 253 indexed citations
12.
Zappasodi, Roberta, Marilena V. Iorio, Monica Tortoreto, et al.. (2014). Pleiotropic antitumor effects of the pan‐HDAC inhibitor ITF2357 against c‐Myc‐overexpressing human B‐cell non‐Hodgkin lymphomas. International Journal of Cancer. 135(9). 2034–2045. 17 indexed citations
13.
Piovan, Claudia, Dario Palmieri, Gianpiero Di Leva, et al.. (2012). Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer. Molecular Oncology. 6(4). 458–472. 130 indexed citations
14.
Iorio, Marilena V. & Carlo M. Croce. (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Molecular Medicine. 4(3). 143–159. 1402 indexed citations breakdown →
15.
Iorio, Marilena V., Patrizia Casalini, Claudia Piovan, et al.. (2009). microRNA-205 Regulates HER3 in Human Breast Cancer. Cancer Research. 69(6). 2195–2200. 298 indexed citations
16.
Casalini, Patrizia & Marilena V. Iorio. (2009). MicroRNAs and future therapeutic applications in cancer.. PubMed. 14 Suppl 1. S17–22. 25 indexed citations
17.
Iorio, Marilena V., Rosa Visone, Gianpiero Di Leva, et al.. (2007). MicroRNA Signatures in Human Ovarian Cancer. Cancer Research. 67(18). 8699–8707. 1199 indexed citations breakdown →
18.
Volinia, Stefano, George A. Calin, Chang‐Gong Liu, et al.. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences. 103(7). 2257–2261. 4730 indexed citations breakdown →
19.
Cimmino, Amelia, George A. Calin, Muller Fabbri, et al.. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences. 102(39). 13944–13949. 2787 indexed citations breakdown →
20.
Iorio, Marilena V., Manuela Ferracin, Chang‐Gong Liu, et al.. (2005). MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Research. 65(16). 7065–7070. 3320 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026